Oppenheimer raises Biogen price target on growing investor confidence By Investing.com
[ad_1] © Reuters Oppenheimer raises Biogen price target on growing investor confidence Oppenheimer raised the price target on Biogen (NASDAQ:) to $295.00 from $280.00 while...
Alzheimer’s patient groups pressure U.S. to pay for Biogen drug By Reuters
[ad_1] © Reuters. An advertisement aimed at loosening proposed restrictions on new Alzheimer’s treatments is seen in this undated handout image. UsAgainstAlzheimer?s Action/Handout via REUTERS...